Basiliximab is a medication used to prevent organ rejection in transplant patients, particularly those undergoing kidney transplantation. It is a monoclonal antibody that works by inhibiting the action of interleukin-2 (IL-2), a protein that plays a key role in the immune response. By blocking IL-2, basiliximab helps suppress the immune system’s attack on the transplanted organ. It is typically administered as an intravenous infusion before and after the transplant surgery. basiliximab is often used in combination with other immunosuppressive drugs to improve transplant outcomes and prevent rejection.
